<DOC>
	<DOCNO>NCT02789592</DOCNO>
	<brief_summary>The purpose study determine whether melatonin prolonged-release ( PR ) clonazepam effective safe treatment rapid eye movement behavior disorder ( RBD ) patient Parkinson 's disease ( PD ) .</brief_summary>
	<brief_title>Efficacy Safety Melatonin PR Clonazepam Patients With REM Sleep Behavior Disorder Parkinson Disease</brief_title>
	<detailed_description>RBD one representative non-motor symptom PD . Patients RBD show dream-enacting behavior punch , kick , sing , scream , somnambulism . These interfere sleep quality increase risk fall bed physical injury patient sleep partner . Therefore , quality life patient sleep partner negatively influence presence RBD . Clonazepam use treatment choice RBD . However , efficacy clonazepam proven clinical trial . Clonazepam several side effect could problematic PD patient increase fall-down risk , daytime somnolence , cognitive decline . Melatonin second-line treatment option RBD , one randomize crossover trial evaluate efficacy melatonin RBD . Finally , study evaluate compare efficacy safety melatonin clonazepam treatment RBD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>REM Sleep Behavior Disorder</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<criteria>Subject enrol voluntarily understood content clinical trial Subject diagnose Parkinson disease ( PD ) Hoehn Yahr ( H &amp; Y ) stage 1 , 2 , 3 Existence caregiver provide information symptom rapid eye movement sleep disorder ( RBD ) participant RBD frequency one per week Existence RBD answer `` yes '' question ( RBD1Q ) : `` Have ever tell , suspect , seem 'act dream ' asleep ( example , punching , flail arm air , make run movement , etc. ) ? '' Good compliance reporting PGI score sleep diary Existence cognitive decline hard participate clinical trial Hypersensitivity melatonin clonazepam Previous melatonin clonazepam treatment within 1 month Changing antiparkinsonian medication within 1 month Current treatment sedative hypnotic bedtime Diagnosed epilepsy current treatment antiepileptic drug Severe trauma history due RBD Lactating , pregnant , possible pregnant Subject confusion visual hallucination daytime Diagnosed obstructive sleep apnea severe snore Diagnosed parasomnia Presence severe psychiatric illness Alcoholics drug abuser Myasthenia gravis Acute narrowangle glaucoma Prior participation clinical trial within 3 month Presence severe comorbidities cancer Existence illness problem make difficult enrolled trial judge clinician</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>REM Sleep Behavior Disorder</keyword>
	<keyword>Parkinson Disease</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Clonazepam</keyword>
</DOC>